Veracyte Inc VCYT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/15/24 EDT
19.37quote price arrow down-0.86 (-4.25%)
Volume
772,598
52 week range
19.12 - 30.52
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close19.37
  • 52 Week High30.52
  • 52 Week High Date07/18/23
  • 52 Week Low19.12
  • 52 Week Low Date04/15/24

Key Stats

  • Market Cap1.519B
  • Shares Out78.44M
  • 10 Day Average Volume0.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.65
  • YTD % Change-29.59

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close19.37
  • 52 Week High30.52
  • 52 Week High Date07/18/23
  • 52 Week Low19.12
  • 52 Week Low Date04/15/24
  • Market Cap1.519B
  • Shares Out78.44M
  • 10 Day Average Volume0.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.65
  • YTD % Change-29.59

RATIOS/PROFITABILITY

  • EPS (TTM)-1.02
  • P/E (TTM)-18.96
  • Fwd P/E (NTM)-65.00
  • EBITDA (TTM)9.732M
  • ROE (TTM)-7.02%
  • Revenue (TTM)361.051M
  • Gross Margin (TTM)68.73%
  • Net Margin (TTM)-20.61%
  • Debt To Equity (MRQ)0.01%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Veracyte Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Veracyte, Inc. is a global diagnostics company. The Company enables clinicians with insights they need to guide and assure patients. The Company offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for...
Robert Epstein M.D.
Independent Chairman of the Board
Marc Stapley
Chief Executive Officer, Director
Rebecca Chambers
Chief Financial Officer
Address
6000 Shoreline Court, Suite 300
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
CPRX
Catalyst Pharmaceuticals Inc
15.39+0.17+1.12%
ZLAB
Zai Lab Ltd
14.20-0.11-0.77%
DVAX
Dynavax Technologies Corp
11.69-0.15-1.27%
ADMA
ADMA Biologics Inc
5.98-0.04-0.66%
MDXG
MiMedx Group Inc
6.35-0.09-1.40%